Technical Analysis for NVSEF - Novartis Ag Basl

Grade Last Price % Change Price Change
grade B 90.19 2.72% 2.3900
NVSEF closed up 2.72 percent on Wednesday, August 21, 2019, on 1.33 times normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Flat Flat
See historical NVSEF trend table...

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Cup with Handle Other 0.00%
Multiple of Ten Bullish Other 0.00%
Gapped Up Strength 0.00%
180 Bearish Setup Bearish Swing Setup 2.72%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 2.72%
Cup with Handle Other 2.72%
Narrow Range Bar Range Contraction 2.72%
Inside Day Range Contraction 2.72%

Older signals for NVSEF ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company's Innovative Medicines segment offers patented prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology and dermatology, respiratory, cardio-metabolic, and established medicine products. The company's Sandoz segment provides active ingredients and finished dosage forms of pharmaceuticals in cardiovascular, central nervous system, dermatology, gastrointestinal and hormonal therapy, metabolism, oncology, ophthalmic, pain, and respiratory areas; and finished dosage form anti-infective. It also provides active pharmaceutical ingredients and intermediates primarily antibiotics; protein- or other biotechnology-based products, including biosimilars; and biotechnology manufacturing services. The company's Alcon segment offers intraocular lenses and equipment for cataract procedures; equipment, instruments, and devices for vitreoretinal surgeries; surgical equipment and diagnostic devices for refractive surgical procedures; and devices to treat glaucoma. It also provides viscoelastics, surgical solutions, diagnostic ophthalmic products, surgical packs, and other disposable products for cataract and vitreoretinal surgery. In addition, this segment offers contact lenses and ocular health products; over-the-counter ophthalmic products; eye drops for the temporary relief of ocular itching due to allergies; vitamins for ocular health; and iLux Device, a therapeutic device used to treat meibomian gland dysfunction. Novartis AG has collaboration agreements with Xencor; Surface Oncology; Ligand Pharmaceuticals, Inc.; Amgen; University of California, Berkeley; Bristol-Myers Squibb; IBM Watson Health; Allergan plc; Science 37, Inc.; Bill & Melinda Gates Foundation; PEAR Therapeutics; Pfizer; and Conatus Pharmaceuticals Inc. The company was founded in 1895 and is headquartered in Basel, Switzerland.
Medicine Health Biotechnology Healthcare Pharmaceuticals Pharmaceutical Industry In China Pain Surgery Healthcare Providers Healthcare Products Active Pharmaceutical Ingredients Neuroscience Antibiotics Ophthalmology Glaucoma Allergies Cataract Diagnostic Devices Medicine Products University Of California Biotechnology Based Products Hormonal Therapy Surgical Equipment
Is NVSEF a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 0 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 96.5
52 Week Low 70.95
Average Volume 34,730
200-Day Moving Average 87.3163
50-Day Moving Average 90.6283
20-Day Moving Average 90.3595
10-Day Moving Average 89.824
Average True Range 1.7511
ADX 10.91
+DI 35.2612
-DI 35.8946
Chandelier Exit (Long, 3 ATRs ) 89.59669999999999
Chandelier Exit (Short, 3 ATRs ) 91.85329999999999
Upper Bollinger Band 94.0451
Lower Bollinger Band 86.6739
Percent B (%b) 0.48
BandWidth 8.157637
MACD Line -0.4358
MACD Signal Line -0.2484
MACD Histogram -0.1874
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 91.9750
Resistance 3 (R3) 91.7767 90.9833 91.6775
Resistance 2 (R2) 90.9833 90.5288 91.0825 91.5783
Resistance 1 (R1) 90.5867 90.2479 90.7850 90.7850 91.4791
Pivot Point 89.7933 89.7933 89.8925 89.8925 89.7933
Support 1 (S1) 89.3967 89.3388 89.5950 89.5950 88.9009
Support 2 (S2) 88.6033 89.0579 88.7025 88.8017
Support 3 (S3) 88.2067 88.6033 88.7025
Support 4 (S4) 88.4050